ORIONPHARM Stock Overview
Engages in the discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Orion Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳71.20 |
| 52 Week High | ৳91.80 |
| 52 Week Low | ৳61.30 |
| Beta | -0.57 |
| 11 Month Change | -6.32% |
| 3 Month Change | 4.40% |
| 1 Year Change | -10.55% |
| 33 Year Change | 34.85% |
| 5 Year Change | 114.46% |
| Change since IPO | 13.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORIONPHARM | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 0.4% | 5.0% | 3.9% |
| 1Y | -10.6% | -20.3% | -23.8% |
Return vs Industry: ORIONPHARM exceeded the BD Pharmaceuticals industry which returned -20.3% over the past year.
Return vs Market: ORIONPHARM exceeded the BD Market which returned -23.8% over the past year.
Price Volatility
| ORIONPHARM volatility | |
|---|---|
| ORIONPHARM Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 6.8% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in BD Market | 7.6% |
| 10% least volatile stocks in BD Market | 3.4% |
Stable Share Price: ORIONPHARM has not had significant price volatility in the past 3 months.
Volatility Over Time: ORIONPHARM's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 2,716 | Zareen Karim | www.orionpharmabd.com |
Orion Pharma Limited engages in the discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups like anticancer, antibiotics, anti diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products. The company was formerly known as Orion Laboratories Limited and changed its name to Orion Pharma Limited in October 2010.
Orion Pharma Limited Fundamentals Summary
| ORIONPHARM fundamental statistics | |
|---|---|
| Market cap | ৳16.66b |
| Earnings (TTM) | ৳455.46m |
| Revenue (TTM) | ৳11.50b |
36.6x
P/E Ratio1.4x
P/S RatioIs ORIONPHARM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORIONPHARM income statement (TTM) | |
|---|---|
| Revenue | ৳11.50b |
| Cost of Revenue | ৳9.33b |
| Gross Profit | ৳2.17b |
| Other Expenses | ৳1.71b |
| Earnings | ৳455.46m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 18.85% |
| Net Profit Margin | 3.96% |
| Debt/Equity Ratio | 95.8% |
How did ORIONPHARM perform over the long term?
See historical performance and comparison